Home LiteratureArticle Details
PMID: 8105371 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes.

Molecular and cellular biology ·Vol. 13 ·No. 10 ·1993-10-00 ·Pages 6180-9

Malim MH, Cullen BR

Abstract

Although a great deal is known about the regulation of gene expression in terms of transcription, relatively little is known about the modulation of pre-mRNA processing. In this study, we exploited a genetically regulated system, human immunodeficiency virus type 1 (HIV-1) and its trans-activator Rev, to examine events that occur between the synthesis of pre-mRNA in the nucleus and the translation of mRNA in the cytoplasm. Unlike the majority of eukaryotic pre-mRNAs whose introns are efficiently recognized and spliced prior to nucleocytoplasmic transport, HIV-1 mRNAs containing functional introns must be exported to the cytoplasm for the expression of many viral proteins. Using human T cells containing stably integrated proviruses, we demonstrate that such incompletely spliced viral mRNAs are exported to the cytoplasm only in the presence of the Rev trans-activator. In the absence of Rev, these intron-containing RNAs are sequestered in the T-cell nucleus and either spliced or, more commonly, degraded. Because Rev does not inhibit the expression of fully spliced viral mRNA species in T cells, we propose that Rev, rather than inhibiting viral pre-mRNA splicing, is acting here both to prevent the nuclear degradation of HIV-1 pre-mRNAs and to induce their translocation to the cytoplasm. Taken together, these findings indicate that the cellular factors responsible for the nuclear retention of unspliced pre-mRNAs, although most probably splicing factors, do not invariably commit these RNAs to productive splicing and can, instead, program such transcripts for degradation.

MeSH Terms
Animals CD4-Positive T-Lymphocytes/metabolism,microbiology Cell Line Cell Nucleus/metabolism Cytoplasm/metabolism Gene Products, rev/metabolism Genes, rev HIV-1/genetics,physiology Haplorhini Humans Introns Polymerase Chain Reaction Precipitin Tests Protein Biosynthesis RNA Precursors/metabolism RNA Processing, Post-Transcriptional Transduction, Genetic Viral Proteins/biosynthesis Virus Replication rev Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, rev RNA Precursors Viral Proteins rev Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Malim M H
Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia 19104-6148.
Cullen B R
References (61)
61 references, click to expand
  1. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.
    J Exp Med. 1992 Oct 1;176(4):1197-201 PMID: 1402661
  2. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.
    Mol Cell Biol. 1992 Mar;12(3):1375-86 PMID: 1545819
  3. Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species.
    J Cell Physiol. 1970 Oct;76(2):127-39 PMID: 5500970
  4. The inhibition by DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells.
    Cell. 1976 Nov;9(3):473-80 PMID: 1086720
  5. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.
    Nature. 1985 Feb 7-13;313(6002):450-8 PMID: 2982104
  6. A multicomponent complex is involved in the splicing of messenger RNA precursors.
    Cell. 1985 Aug;42(1):345-53 PMID: 3160482
  7. Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences.
    Cell. 1985 Aug;42(1):355-67 PMID: 3160483
  8. A second post-transcriptional trans-activator gene required for HTLV-III replication.
    Nature. 1986 May 22-28;321(6068):412-7 PMID: 3012355
  9. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
    Cell. 1986 Sep 12;46(6):807-17 PMID: 3638988
  10. Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis.
    Science. 1987 May 15;236(4803):837-40 PMID: 3033827
  11. Isolation of differentially expressed genes.
    Methods Enzymol. 1987;152:423-32 PMID: 3657581
  12. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
    Science. 1988 Feb 5;239(4840):617-22 PMID: 3277274
  13. Quantitative infectivity assay for HIV-1 and-2.
    Nature. 1988 Mar 31;332(6163):469-70 PMID: 3281026
  14. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1988 Apr;85(7):2071-5 PMID: 2832844
  15. Subcellular localization of the human immunodeficiency virus trans-acting art gene product.
    J Virol. 1988 Jul;62(7):2498-501 PMID: 2836628
  16. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes.
    Nature. 1988 Sep 8;335(6186):181-3 PMID: 3412474
  17. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.
    Nature. 1988 Oct 20;335(6192):738-40 PMID: 3262832
  18. Phosphorylation of the rev gene product of human immunodeficiency virus type 1.
    J Virol. 1988 Dec;62(12):4801-4 PMID: 2846891
  19. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.
    J Virol. 1989 Mar;63(3):1265-74 PMID: 2783738
  20. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Nature. 1989 Mar 16;338(6212):254-7 PMID: 2784194
  21. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1495-9 PMID: 2784208
  22. Regulation of human immunodeficiency virus env expression by the rev gene product.
    J Virol. 1989 May;63(5):1959-66 PMID: 2704072
  23. Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm.
    Cell. 1989 May 19;57(4):573-83 PMID: 2655924
  24. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.
    Proc Natl Acad Sci U S A. 1989 May;86(10):3857-61 PMID: 2726755
  25. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization.
    Cell. 1989 Jun 30;57(7):1155-65 PMID: 2736624
  26. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.
    J Virol. 1989 Sep;63(9):3708-13 PMID: 2760980
  27. Functional significance of phosphorylation to the human immunodeficiency virus Rev protein.
    J Virol. 1989 Oct;63(10):4438-40 PMID: 2550674
  28. HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus.
    Cell. 1989 Oct 6;59(1):113-20 PMID: 2676192
  29. Identification of functional U1 snRNA-pre-mRNA complexes committed to spliceosome assembly and splicing.
    Cell. 1989 Oct 20;59(2):349-58 PMID: 2529976
  30. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.
    Proc Natl Acad Sci U S A. 1989 Nov;86(21):8222-6 PMID: 2682638
  31. Regulation by HIV Rev depends upon recognition of splice sites.
    Cell. 1989 Dec 1;59(5):789-95 PMID: 2686839
  32. Sequence-specific RNA binding by the HIV-1 Rev protein.
    Nature. 1989 Dec 7;342(6250):714-6 PMID: 2556643
  33. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9544-8 PMID: 2687883
  34. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9549-53 PMID: 2687884
  35. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Nature. 1989 Dec 14;342(6251):816-9 PMID: 2481237
  36. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.
    J Virol. 1990 Jun;64(6):2519-29 PMID: 2335812
  37. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
    J Virol. 1990 Jul;64(7):3391-8 PMID: 2191150
  38. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.
    Cell. 1990 Jun 29;61(7):1271-6 PMID: 2364429
  39. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
    J Virol. 1990 Aug;64(8):3716-25 PMID: 2164593
  40. Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein.
    J Virol. 1990 Aug;64(8):3734-41 PMID: 2196381
  41. Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1.
    J Virol. 1990 Oct;64(10):5226-9 PMID: 2398545
  42. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.
    J Virol. 1990 Nov;64(11):5448-56 PMID: 2214021
  43. Visna virus encodes a post-transcriptional regulator of viral structural gene expression.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7497-501 PMID: 2170981
  44. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7598-602 PMID: 2217190
  45. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91 PMID: 2217212
  46. Rev-dependent expression of human immunodeficiency virus type 1 gp160 in Drosophila melanogaster cells.
    Mol Cell Biol. 1990 Dec;10(12):6152-9 PMID: 2123289
  47. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors.
    Genes Dev. 1991 Feb;5(2):232-43 PMID: 1995415
  48. Human immunodeficiency virus as a prototypic complex retrovirus.
    J Virol. 1991 Mar;65(3):1053-6 PMID: 1995941
  49. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products.
    J Virol. 1991 Mar;65(3):1653-7 PMID: 1825343
  50. Regulation of expression of human immunodeficiency virus.
    New Biol. 1990 Jan;2(1):20-31 PMID: 2078551
  51. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
    Genes Dev. 1991 May;5(5):808-19 PMID: 1827422
  52. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
    Science. 1991 Jul 5;253(5015):71-4 PMID: 1905842
  53. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.
    J Virol. 1991 Aug;65(8):4248-54 PMID: 2072452
  54. Identification of feline immunodeficiency virus rev gene activity.
    J Virol. 1991 Aug;65(8):4539-42 PMID: 1649349
  55. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression.
    J Virol. 1991 Oct;65(10):5305-13 PMID: 1895385
  56. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.
    Cell. 1991 Oct 4;67(1):169-78 PMID: 1913815
  57. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation.
    J Virol. 1991 Nov;65(11):5732-43 PMID: 1656066
  58. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    J Virol. 1992 Jan;66(1):150-9 PMID: 1727477
  59. An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway.
    Genes Dev. 1991 Dec;5(12B):2534-46 PMID: 1836445
  60. Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency.
    J Virol. 1992 Mar;66(3):1809-13 PMID: 1738210
  61. The spliceosome assembly pathway in mammalian extracts.
    Mol Cell Biol. 1992 Oct;12(10):4279-87 PMID: 1383687
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1993-10-00
Pages
6180-9
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC364677
Subset
IM
Grants
NIAID NIH HHS · AI28233 · United States
NIAID NIH HHS · AI29821 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]